In this issue:
Causes of death in patients with metastatic prostate cancer
Atezolizumab and sipuleucel-T for mCRPC
Decision fatigue in low-value prostate cancer screening
Does prostate cancer nomenclature affect management and anxiety
Cause of death during prostate cancer survivorship
Transcriptional profiling of mHSPC
Curative-intent metastasis-directed therapies for oligorecurrent prostate cancer
PSA density during dutasteride treatment
mCRPC with alterations in homologous recombination genes
Radical prostatectomy improves survival in metastatic prostate cancer
Please login below to download this issue (PDF)